This abstract is part of the Presidential Symposium AN OPEN-LABEL, RANDOMISED, PHASE 3 STUDY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): POLLUX

被引：0

作者：

Dimopoulos, M. A. ^{[1
]}

Oriol, A. ^{[2
]}

Nahi, H. ^{[3
,4
]}

Miguel, J. S. ^{[5
]}

Bahlis, N. J. ^{[6
]}

Rabin, N. ^{[7
]}

Orlowski, R. ^{[8
]}

Komarnicki, M. ^{[9
]}

Suzuki, K. ^{[10
]}

Plesner, T. ^{[11
,12
]}

Samoilova, O. S. ^{[13
]}

Yoon, S. S. ^{[14
]}

Yehuda, D. B. ^{[15
]}

Richardson, P. G. ^{[16
]}

Goldschmidt, H. ^{[17
,18
]}

Reece, D. ^{[19
]}

Khokhar, N. ^{[20
]}

O'Rourke, L. ^{[20
]}

Chiu, C. ^{[20
]}

Qin, X. ^{[21
]}

Guckert, M. ^{[20
]}

Ahmadi, T. ^{[20
]}

Moreau, P. ^{[22
]}

机构：

[1] Univ Athens, Athens, Greece

[2] HGTiP, Inst Catala Oncol, Barcelona, Spain

[3] Karolinska Inst, Stockholm, Sweden

[4] Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Stockholm, Sweden

[5] Univ Navarra Clin, CIMA, Pamplona, Spain

[6] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada

[7] Univ Coll London Hosp NHS Trust, Dept Haematol, London, England

[8] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA

[9] Poznan Univ Med Sci, Dept Hematol & Stem Cell Transplantat, Poznan, Poland

[10] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan

[11] Vejle Hosp, Vejle, Denmark

[12] Univ Southern Denmark, Vejle, Denmark

[13] Nizhny Novgorod Reg Clin Hosp, Nizhnii Novgorod, Russia

[14] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[15] Hadassah Hebrew Univ Med Ctr, Hematol Dept, Jerusalem, Israel

[16] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

[17] Univ Hosp Heidelberg, Heidelberg, Germany

[18] German Canc Res Ctr, Heidelberg, Germany

[19] Princess Margaret Canc Ctr, CCRU, Toronto, ON, Canada

[20] Janssen Res & Dev, Spring House, PA USA

[21] Janssen Res & Dev, Horsham, PA USA

[22] Univ Hosp Hotel Dieu, Hematol, Nantes, France

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

LB2238

引用

页码：342 / 342

页数：1

共 50 条

[41] OCEAN: A Phase 3, Randomized, Global Study of Melflufen and Dexamethasone Versus Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Refractory to Lenalidomide [J].

Sonneveld, Pieter ;

Schjesvold, Fredrik ;

Robak, Pawel ;

Rossjey, Viktor ;

Pour, Ludk ;

Minarik, Jiri ;

Delimpasi, Sosana ;

Legic, Wojciech ;

Salogub, Galina ;

Harmenberg, Johan ;

Byrne, Catriona ;

Nordstrom, Eva ;

Richardson, Paul G. .

AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 :S25-S25

[42] Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group [J].

Fazio, Francesca ;

Franceschini, Luca ;

Tomarchio, Valeria ;

Rago, Angela ;

Garzia, Maria Grazia ;

Cupelli, Luca ;

Bongarzoni, Velia ;

Andriani, Alessandro ;

Gumenyuk, Svitlana ;

Tafuri, Agostino ;

Siniscalchi, Agostina ;

Piciocchi, Alfonso ;

De Fabritiis, Paolo ;

De Rosa, Luca ;

di Toritto, Tommaso Caravita ;

Annibali, Ombretta ;

Cantonetti, Maria ;

Petrucci, Maria Teresa .

EJHAEM, 2022, 3 (01) :121-128

[43] DARATUMUMAB COMBINED WITH DEXAMETHASONE AND LENALIDOMIDE OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS: REPORT FROM THE MULTIPLE MYELOMA GIMEMA LAZIO GROUP [J].

Fazio, F. ;

Franceschini, L. ;

Tomarchio, V. ;

Rago, A. ;

Garzia, M. G. ;

Cupelli, L. ;

Bongarzoni, V. ;

Rosati, S. ;

Gumenyku, S. ;

Antolino, G. ;

Siniscalchi, A. ;

Proietti, G. ;

Piciocchi, A. ;

De Fabritiis, P. ;

De Rosa, L. ;

Caravita, T. ;

Annibali, O. ;

Cantonetti, M. ;

Petrucci, M. T. .

HAEMATOLOGICA, 2021, 106 (10) :92-92

[44] Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study [J].

Schjesvold, Fredrik H. ;

Dimopoulos, Meletios-Athanasios ;

Delimpasi, Sosana ;

Robak, Pawel ;

Coriu, Daniel ;

Legiec, Wojciech ;

Pour, Ludek ;

Spicka, Ivan ;

Masszi, Tamas ;

Doronin, Vadim ;

Minarik, Jiri ;

Salogub, Galina ;

Alekseeva, Yulia ;

Lazzaro, Antonio ;

Maisnar, Vladimir ;

Mikala, Gabor ;

Rosinol, Laura ;

Liberati, Anna Marina ;

Symeonidis, Argiris ;

Moody, Victoria ;

Thuresson, Marcus ;

Byrne, Catriona ;

Harmenberg, Johan ;

Bakker, Nicolaas A. ;

Hajek, Roman ;

Mateos, Maria-Victoria ;

Richardson, Paul G. ;

Sonneveld, Pieter .

LANCET HAEMATOLOGY, 2022, 9 (02) :E98-E110

[45] Phase 3 Randomized Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant (MAIA) [J].

Facon, Thierry ;

Kumar, Shaji K. ;

Plesner, Torben ;

Orlowski, Robert Z. ;

Moreau, Philippe ;

Bahlis, Nizar ;

Basu, Supratik ;

Nahi, Hareth ;

Hulin, Cyrille ;

Quach, Hang ;

Goldschmidt, Hartmut ;

O'Dwyer, Michael ;

Perrot, Aurore ;

Venner, Christopher P. ;

Weisel, Katja ;

Mace, Joseph R. ;

Ahmadi, Tahamtan ;

Chiu, Christopher ;

Wang, Jianping ;

Van Rampelbergh, Rian ;

Uhlar, Clarissa M. ;

Kobos, Rachel ;

Qi, Ming ;

Usmani, Saad Z. .

BLOOD, 2018, 132

[46] Phase 3 randomized study of Daratumumab plus lenalidomide and Dexamethasone (D-Rd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma (NDMM) ineligible for transplant (MAIA) [J].

Weisel, K. ;

Facon, T. ;

Kumar, S. ;

Plesner, T. ;

Orlowski, R. Z. ;

Moreau, P. ;

Bahlis, N. ;

Basu, S. ;

Nahi, H. ;

Hulin, C. ;

Quach, H. ;

Goldschmidt, H. ;

O'Dwyer, M. ;

Perrot, A. ;

Venner, C. P. ;

Mace, J. R. ;

Ahmadi, T. ;

Chiu, C. ;

Wang, J. ;

van Rampelbergh, R. ;

Uhlar, C. M. ;

Kobos, R. ;

Qi, M. ;

Usmani, S. Z. .

ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 :194-194

[47] Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study [J].

Plesner, Torben ;

Arkenau, Hendrik-Tobias ;

Gay, Francesca ;

Minnema, Monique C. ;

Boccadoro, Mario ;

Moreau, Philippe ;

Cavenagh, Jamie ;

Perrot, Aurore ;

Laubach, Jacob P. ;

Krejcik, Jakub ;

Ahmadi, Tahamtan ;

de Boer, Carla ;

Chen, Diana ;

Chiu, Christopher ;

Schecter, Jordan M. ;

Richardson, Paul G. .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (03) :E35-E39

[48] PHASE 3 RANDOMISED CONTROLLED STUDY OF DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: CASTOR [J].

Palumbo, A. ;

Chanan-Khan, A. ;

Weisel, K. ;

Nooka, A. K. ;

Masszi, T. ;

Beksac, M. ;

Spicka, I. ;

Hungria, V. ;

Munder, M. ;

Mateos, M. V. ;

Mark, T. ;

Qi, M. ;

Schecter, J. ;

Amin, H. ;

Qin, X. ;

Deraedt, W. ;

Ahmadi, T. ;

Spencer, A. ;

Sonneveld, P. .

HAEMATOLOGICA, 2016, 101 :340-341

[49] Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study(vol 396, 186, 2020) [J].

Dimopoulos, M. ;

Quach, H. ;

Mateos, M-, V ;

Landgren, Ola ;

Leleu, Xavier ;

Siegel, David ;

Weisel, Katja ;

Yang, Hui ;

Klippel, Zandra ;

Zahlten-Kumeli, Anita ;

Usmani, Saad Z. .

LANCET, 2020, 396 (10249) :466-466

[50] ELOQUENT-2: A phase III, randomized, open-label study of lenalidomide (Len)/dexamethasone (dex) with/without elotuzumab (Elo) in patients (pts) with relapsed/refractory multiple myeloma (RRMM). [J].

Lonial, Sagar ;

Dimopoulos, Meletios A. ;

Palumbo, Antonio ;

White, Darrell ;

Grosicki, Sebastian ;

Spicka, Ivan ;

Walter-Croneck, Adam ;

Moreau, Philippe ;

Mateos, Maria-Victoria ;

Magen-Nativ, Hila ;

Belch, Andrew ;

Reece, Donna Ellen ;

Beksac, Meral ;

Taniwaki, Masafumi ;

Roellig, Christoph ;

Singhal, Anil K. ;

Katz, Jessica ;

Bleickardt, Eric W. ;

Poulart, Valerie ;

Richardson, Paul G. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →